KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) FCF Margin: 2009-2025

Historic FCF Margin for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to 14.88%.

  • Quest Diagnostics' FCF Margin rose 483.00% to 14.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.84%, marking a year-over-year increase of 211.00%. This contributed to the annual value of 9.21% for FY2024, which is 13.00% down from last year.
  • Per Quest Diagnostics' latest filing, its FCF Margin stood at 14.88% for Q3 2025, which was down 5.78% from 15.79% recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' FCF Margin peaked at 23.71% during Q1 2021, and registered a low of -1.42% during Q1 2023.
  • Over the past 3 years, Quest Diagnostics' median FCF Margin value was 11.18% (recorded in 2024), while the average stood at 10.17%.
  • In the last 5 years, Quest Diagnostics' FCF Margin soared by 1,471bps in 2021 and then slumped by 1,739bps in 2023.
  • Quest Diagnostics' FCF Margin (Quarterly) stood at 12.28% in 2021, then slumped by 427bps to 8.02% in 2022, then spiked by 1,187bps to 19.89% in 2023, then plummeted by 688bps to 13.01% in 2024, then skyrocketed by 483bps to 14.88% in 2025.
  • Its last three reported values are 14.88% in Q3 2025, 15.79% for Q2 2025, and 7.43% during Q1 2025.